This invention relates to crystals of the human Gremlin-1 protein, and the human Gremlin-1 protein in complex with an inhibitory antibody. The invention also relates to the structure of human Gremlin-1 (on its own, or in complex with the antibody) and uses of these structures in screening for agents which modulate Gremlin-1 activity. The invention further provides antibodies which bind an allosteric inhibitory site on Gremlin-1, together with pharmaceutical compositions and medical uses of such antibodies and agents identified by the screening methods.本發明係關於人類Gremlin-1蛋白及與抑制抗體複合之人類Gremlin-1蛋白之結晶。本發明亦關於人類Gremlin-1 (獨自,或與抗體複合)之結構及此等結構在篩檢調節Gremlin-1活性之藥劑中的用途。本發明另外提供結合Gremlin-1上之異位抑制位點之抗體,以及此類抗體之醫藥組合物及醫學用途及藉由篩檢方法鑑別之藥劑。